Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018

Antimicrobial resistance in  is a major public health concern, in particular resistance to ceftriaxone which is the last available drug for empirical monotherapy for gonorrhoea. Here, we report further international spread of the  FC428 clone associated with ceftriaxone resistance and intermediate resistance to azithromycin.

Article: EuroSurveillance

Effective Surveillance  
Back


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed